Financial Year |
March 31 2023 |
Monetary Funds |
5,669,853,678.24 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
231,993,461.53 |
Accounts Receivable |
11,038,657,877.49 |
Advances to Suppliers |
256,031,058.52 |
Other Receivables |
937,440,021.48 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
9,900,000.00 |
Inventories |
1,367,397,124.40 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
358,436,273.30 |
Other Current Assets |
969,638,290.18 |
Total Current Assets |
25,226,831,583.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
2,140,046,874.28 |
Long-term Equity Investment |
1,734,473,739.23 |
Investment Properties |
546,829,700.00 |
Fixed Assetes |
6,139,121,266.67 |
Under-construction Projects |
1,148,944,347.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
48,546,364,944.88 |
R&D expenses |
2,945,766.23 |
Goodwill |
1,039,547,873.27 |
Long-Term Deferred and Prepaid Expenses |
106,098,773.76 |
Deferred Income Tax Assets |
245,638,784.90 |
Other Non-Current Assets |
18,467,516,848.98 |
Sub-Total of Non-Current Assets |
80,429,874,510.94 |
Total Assets |
105,656,706,094.02 |
Short-Term Loans |
1,726,849,919.90 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
11,256,017,806.66 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
330,665,761.06 |
Taxes Payable |
442,257,162.94 |
Interest Payable |
-- |
Dividend Payable |
46,635,564.75 |
Other payables |
2,582,387,727.96 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,642,225,974.04 |
Other Current Liabilities |
2,642,575,717.90 |
Sub-Total of Current Liabilities |
26,655,671,999.32 |
Long-term Loans |
31,736,460,425.59 |
Bonds Payable |
3,800,000,000.00 |
Long-Term Accounts Payable |
1,585,890,338.54 |
Special Payable |
-- |
Estimatied Liabilities |
68,459,605.03 |
Deferred Income Tax Liabilities |
607,837,033.38 |
Other Non-Current Liabilities |
33,883,157.71 |
Sub-Total of Non-Current Liabilities |
38,693,459,350.69 |
Total Liabilities |
65,349,131,350.01 |
Paid-In Capital(Or Share Stock) |
7,340,590,677.00 |
Capital Surplus |
3,627,477,137.04 |
Surplus Reserve |
1,547,118,531.48 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
6,073,403,329.78 |
Minority Stockholder's Interest |
11,283,541,942.39 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,024,032,801.62 |
Owner's Equity(Stockholder's Equity) |
40,307,574,744.01 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
105,656,706,094.02 |